This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
deCODE genetics ehf
deCODE genetics ehf, a pioneering biotechnology company founded in 1996, is headquartered in Reykjavik, Iceland. Renowned for its innovative contributions to the fields of genetics and genomics, deCODE genetics focuses on understanding the genetic basis of human diseases, leveraging Iceland's unique population for research. The company offers a range of services, including genetic testing and analysis, which are distinguished by their comprehensive data integration and population-based insights. With a strong emphasis on precision medicine, deCODE genetics has established itself as a leader in the industry, achieving significant milestones such as the sequencing of the Icelandic genome. Recognised for its contributions to both scientific research and healthcare, deCODE genetics continues to advance the understanding of complex diseases, solidifying its position as a key player in the global biotechnology landscape.
DitchCarbon Score
How does deCODE genetics ehf's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
deCODE genetics ehf's score of 46 is higher than 71% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
deCODE genetics ehf, headquartered in Iceland, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Amgen Inc., which influences its climate commitments and reporting practices. As part of its corporate family relationship, deCODE genetics may align its climate initiatives with those of Amgen Inc., which has established various reduction targets and initiatives. However, specific reduction targets or achievements for deCODE genetics are not detailed in the available information. The absence of direct emissions data suggests that deCODE genetics is still in the process of developing its own climate strategy or may rely on the broader commitments of its parent company. As the industry increasingly prioritises sustainability, it is expected that deCODE genetics will adopt similar measures to address carbon emissions and contribute to climate action.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 144,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 000,000,000 | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 290,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | - | 000,000,000 | 000,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | - | - | - | - | - | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
deCODE genetics ehf is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
